NIDDK is offering a grant for ancillary studies to expand the investigation of genes and physiological domains related to inflammatory bowel disease (IBD). The grant aims to support exploratory studies that involve collaborations with experts outside the IBD Genetics Consortium to explore new genes and IBD-related phenotypes. Projects may include developing novel experimental platforms or analytic methods. This grant is not for duplicating ongoing or completed studies within the Consortium and does not cover multi-site clinical trials. Closing date for applications is Feb 21, 2020.
Opportunity ID: 299517
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-17-018 |
| Funding Opportunity Title: | Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 18, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Feb 21, 2020 |
| Current Closing Date for Applications: | Feb 21, 2020 |
| Archive Date: | Mar 28, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities State governments Independent school districts Native American tribal governments (Federally recognized) Special district governments For profit organizations other than small businesses Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC), in collaboration with the International IBD Genetics Consortium, has identified about 200 susceptibility loci for IBD. The IBDGC has recently been awarded renewed funding to identify causal genes and genetic variants within these loci, and to elucidate the mechanisms through which they contribute to the pathophysiology of IBD. However, the IBDGC’s current resources permit them to explore the functions of only a limited set of genes within a limited set of physiological domains. The purpose of this FOA is to expand the number of genes and range of IBD-related phenotypes and physiological domains under study by means of collaborations of the IBDGC with investigators with expertise complementary to that of their own members. This FOA is intended to support highly exploratory studies which may require development and testing of novel experimental platforms or analytic methods. Proposed studies must not duplicate studies either ongoing or already completed by the IBDGC. Multi-site clinical trials will not be considered responsive to this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00237140 | Feb 20, 2018 | Feb 21, 2020 | View |
Package 1
Mandatory forms
299517 RR_SF424_2_0-2.0.pdf
299517 PHS398_CoverPageSupplement_4_0-4.0.pdf
299517 RR_OtherProjectInfo_1_4-1.4.pdf
299517 PerformanceSite_2_0-2.0.pdf
299517 RR_KeyPersonExpanded_2_0-2.0.pdf
299517 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299517 RR_Budget_1_4-1.4.pdf
299517 RR_SubawardBudget30_1_4-1.4.pdf
299517 PHS398_ModularBudget_1_2-1.2.pdf
299517 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
